| Methods for converting cysteine to dehydroalanine on peptides and proteins JM Chalker, SB Gunnoo, O Boutureira, SC Gerstberger, ... Chemical Science 2 (9), 1666-1676, 2011 | 389 | 2011 |
| Chemical Protein Modification through Cysteine SB Gunnoo, A Madder ChemBioChem 17 (7), 529-553, 2016 | 383 | 2016 |
| Visible‐Light‐Mediated Selective Arylation of Cysteine in Batch and Flow C Bottecchia, M Rubens, SB Gunnoo, V Hessel, A Madder, T Noël Angewandte Chemie 129 (41), 12876-12881, 2017 | 110 | 2017 |
| Bioconjugation–using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers SB Gunnoo, A Madder Organic & Biomolecular Chemistry 14 (34), 8002-8013, 2016 | 79 | 2016 |
| Bioorthogonal dual functionalization of self-assembling peptide fibers ZN Mahmoud, SB Gunnoo, AR Thomson, JM Fletcher, DN Woolfson Biomaterials 32 (15), 3712-3720, 2011 | 75 | 2011 |
| Engineering chirally blind protein pseudocapsids into antibacterial persisters IE Kepiro, I Marzuoli, K Hammond, X Ba, H Lewis, M Shaw, SB Gunnoo, ... ACS nano 14 (2), 1609-1622, 2019 | 50 | 2019 |
| Pyrazinium salts as efficient organocatalysts of mild oxidations with hydrogen peroxide P Ménová, F Kafka, H Dvořáková, S Gunnoo, M Šanda, R Cibulka Advanced Synthesis & Catalysis 353 (6), 865-870, 2011 | 35 | 2011 |
| Creation of a gated antibody as a conditionally functional synthetic protein SB Gunnoo, HM Finney, TS Baker, AD Lawson, DC Anthony, BG Davis Nature Communications 5 (1), 4388, 2014 | 29 | 2014 |
| Methods for converting cysteine to dehydroalanine on peptides and proteins Chem JM Chalker, SB Gunnoo, O Boutureira, SC Gerstberger, ... Sci 2 (9), 1666, 2011 | 14* | 2011 |
| Decoration of trastuzumab with short oligonucleotides: synthesis and detailed characterization AM Carvalho, A Manicardi, CV Montes, SB Gunnoo, RJ Schneider, ... Organic & Biomolecular Chemistry 15 (42), 8923-8928, 2017 | 8 | 2017 |
| Reviving old protecting group chemistry for site-selective peptide–protein conjugation SB Gunnoo, A Iyer, W Vannecke, KW Decoene, T Hebbrecht, J Gettemans, ... Chemical Communications 54 (84), 11929-11932, 2018 | 7 | 2018 |
| P. 120 unlocking the potential of oligonucleotide therapeutics for Duchenne muscular dystrophy through enhanced delivery M Mellion, J McArthur, A Holland, S Gunnoo, S Ching, R Johnson, C Irwin, ... Neuromuscular Disorders 32, S99, 2022 | 1 | 2022 |
| METHODS OF TREATING MYOTONIC DYSTROPHY TYPE 1 USING PEPTIDE-OLIGONUCLEOTIDE CONJUGATES C Godfrey, S Bracegirdle, A Holland, S Gunnoo US Patent App. 18/281,700, 2024 | | 2024 |
| Decoration of trastuzumab with short oligonucleotides: synthesis and detailed characterization R Schneider, AM Carvalho, A Manicardi, CV Montes, SB Gunnoo, ... | | 2017 |
| Site-selective peptide and protein labelling & crosslinking E Antonatou, SB Gunnoo, W Vannecke, A Madder | | 2016 |
| Site-specific chemical modification of antibodies for the modulation of function SB Gunnoo University of Oxford, 2013 | | 2013 |
